This booklet by FTA Watch is aimed at disseminating information to international
civil society for the purpose of sharing the analyses and experience of the
FTA struggle in Thailand.
Pharmaceutical companies are using free-trade deals like CAFTA to eliminate
global competition — and deny poor patients access to cheaper generic
With many Peruvians already dying from treatable illness due to difficulties in accessing drugs, a UN human rights expert has expressed "deep concern" that an eventual US-Peru Free Trade Agreement (FTA) could deprive millions more of essential drugs made unaffordable by stronger protection of patents.
With many Peruvians already dying from treatable illness due to difficulties in accessing drugs, a United Nations human rights expert today voiced deep concern that an eventual United States-Peru Free Trade Agreement (FTA) could deprive millions more of essential drugs made unaffordable by stronger protection of patents.
The Pharmaceutical Research and Manufacturers of America, which represents 67 parent companies and subsidiaries that develop and make prescription and over-the-counter drugs, listed contacts with the government’s top officials overseeing international trade agreements on more lobbying reports than it did for contacts with the Food and Drug Administration, which directly oversees the industry’s products.
After tiptoeing around the issue for months, Thailand’s trade negotiators will have to finally reveal where they stand on the life-or-death question of producing cheap, generic anti-AIDS drugs.
Looking at the experience of Jordan’s pharmaceutical sector, this paper shows that the expected benefits from bilateral agreements between developed and developing countries have been largely overestimated while the costs underestimated.
As Thailand prepares for new rounds of free trade
talks with Japan and the United States, AIDS activists are voicing
increasing concern that patients here could lose access to cheap,
When George W. Bush and the U.S. pharmaceutical industry team up in Washington, you know it’s bad news for U.S. consumers. Now they are taking their show on the road — to Central America.
India and the Bay of Bengal Initiative for Multisectoral Technical and Economic Cooperation (Bimstec) member countries plan to sign a deal to provide access to each others’ markets for the pharmaceuticals and services sectors.
After letting health advocates air their opposition to the Thai-US free trade agreement (FTA) for more than a year, the Public Health Ministry yesterday unveiled its position on how Thailand should deal with drug patents.
17 NGOs from Switzerland, Norway and Liechtenstein submitted today a request to the UN Special Rapporteur on the right to health. They urge him to warn the four member states of the European Free Trade Association (EFTA: Switzerland, Norway, Iceland and Liechtenstein) not to restrict access to affordable generic medicines in Thailand.
Doctors have been warned not to fall into the fierce marketing trap of multinational drug companies which have a ’’hidden agenda’’ to sell expensive products.
The UN Committee on the Rights of the Child in recommendations made public this week warned that Free Trade Agreements (FTAs) may negatively affect
access to affordable medicines and social services for the poor.
Thailand was Robert Zoellick’s first stop on a week-long visit to Southeast Asia to discuss economic, security and political issues.
The Associated Chambers of Commerce and Industry of India sees tremendous scope for enhancing economic ties with Europe and has mooted a four pronged strategy for expanding India’s trade basket with the enlarged EU in areas such as information technology & communication, biotech & pharmaceuticals, agro foods processing and textiles.
The United States and the Southern African trade bloc are set to revive free trade talks next month, but analysts say intellectual property rights for urgently needed AIDS drugs remain a stumbling block.
The third round of Thailand-US free trade agreement (FTA) negotiations ended on 8 April with great disappointment for civil society activists because people’s demand and concerns were cast aside.
Public health experts fear that hope might fade for thousands of the region’s chronically ill if the Dominican Republic-Central American Free Trade Agreement, known as CAFTA, is approved this year.
During the ninth round of negotiations of a free trade agreement between the United States and three South American nations in the Andean region — Colombia, Peru and Ecuador — Peruvian President Alejandro Toledo called for ”greater flexibility” on the part of Washington.